Circulation, ISSN 0009-7322, 11/2016, Volume 134, Issue Suppl_1 Suppl 1, pp. A13218 - A13218
IntroductionCSL112 is a novel formulation of human apolipoprotein A-I (apoA-I) suitable for intravenous infusion, currently in development for reducing the...
Journal Article
Circulation, ISSN 0009-7322, 11/2016, Volume 134, Issue 19
Journal Article
Circulation, ISSN 0009-7322, 11/2015, Volume 132, Issue 19
Journal Article
Circulation, ISSN 0009-7322, 11/2014, Volume 130, Issue 22
Journal Article
Journal of Crohn's and Colitis, ISSN 1873-9946, 05/2018, Volume 12, Issue 6, pp. 653 - 661
Background: Anti-TNF prevents postoperative Crohn's disease recurrence in most patients but not all. This study aimed to define the relationship between...
Therapeutic drug monitoring | Anti-TNF | Inflammatory Bowel Disease | Adalimumab | ENDOSCOPIC RECURRENCE | ULCERATIVE-COLITIS | RANDOMIZED-TRIAL | MONOCLONAL-ANTIBODY | adalimumab | anti-TNF | FECAL CALPROTECTIN | ADALIMUMAB DRUG | MAINTENANCE | INFLAMMATORY-BOWEL-DISEASE | TROUGH LEVELS | INFLIXIMAB | GASTROENTEROLOGY & HEPATOLOGY | therapeutic drug monitoring | Recurrence | Leukocyte L1 Antigen Complex - analysis | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Crohn Disease - surgery | Anti-Inflammatory Agents - immunology | Male | Secondary Prevention | Obesity - blood | Crohn Disease - complications | Young Adult | Adalimumab - blood | Adalimumab - pharmacokinetics | Anti-Inflammatory Agents - therapeutic use | Adult | Anti-Inflammatory Agents - pharmacokinetics | Female | Severity of Illness Index | Adalimumab - immunology | Obesity - complications | Postoperative Period | Anti-Inflammatory Agents - blood | Adalimumab - therapeutic use | Feces - chemistry | Crohn Disease - blood | Crohn Disease - drug therapy | Antibodies - blood | Drug Monitoring | Tumor Necrosis Factor-alpha - antagonists & inhibitors
Therapeutic drug monitoring | Anti-TNF | Inflammatory Bowel Disease | Adalimumab | ENDOSCOPIC RECURRENCE | ULCERATIVE-COLITIS | RANDOMIZED-TRIAL | MONOCLONAL-ANTIBODY | adalimumab | anti-TNF | FECAL CALPROTECTIN | ADALIMUMAB DRUG | MAINTENANCE | INFLAMMATORY-BOWEL-DISEASE | TROUGH LEVELS | INFLIXIMAB | GASTROENTEROLOGY & HEPATOLOGY | therapeutic drug monitoring | Recurrence | Leukocyte L1 Antigen Complex - analysis | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Crohn Disease - surgery | Anti-Inflammatory Agents - immunology | Male | Secondary Prevention | Obesity - blood | Crohn Disease - complications | Young Adult | Adalimumab - blood | Adalimumab - pharmacokinetics | Anti-Inflammatory Agents - therapeutic use | Adult | Anti-Inflammatory Agents - pharmacokinetics | Female | Severity of Illness Index | Adalimumab - immunology | Obesity - complications | Postoperative Period | Anti-Inflammatory Agents - blood | Adalimumab - therapeutic use | Feces - chemistry | Crohn Disease - blood | Crohn Disease - drug therapy | Antibodies - blood | Drug Monitoring | Tumor Necrosis Factor-alpha - antagonists & inhibitors
Journal Article
Circulation, ISSN 0009-7322, 11/2015, Volume 132, Issue Suppl_3 Suppl 3, pp. A17107 - A17107
Elevated levels of circulating inflammatory markers predict an unfavorable cardiovascular outcome in acute coronary syndrome patients. CSL112 is human...
Journal Article
Circulation, ISSN 0009-7322, 11/2014, Volume 130, Issue 22
Journal Article
1995, 1st ed., ISBN 9780152001780, xi, 306
Collection of twenty-two mystery stories both new and previously published by Thomas Adcock, Winifred Holtby, Joyce Carol Oates, Sara Paretsky, Barbara...
Horror tales | Short stories | Detective and mystery stories
Horror tales | Short stories | Detective and mystery stories
Book
British Journal of Surgery, ISSN 0007-1323, 01/2019, Volume 106, Issue 2, pp. e103 - e112
Background The World Health Organization (WHO) Surgical Safety Checklist has fostered safe practice for 10 years, yet its place in emergency surgery has not...
SURGERY | IMPLEMENTATION | BARRIERS | HEALTH | Elective Surgical Procedures - statistics & numerical data | Prospective Studies | World Health Organization | Humans | Middle Aged | Patient Safety - statistics & numerical data | Checklist - statistics & numerical data | Male | Survival Rate | Laparotomy - mortality | Digestive System Surgical Procedures - statistics & numerical data | Elective Surgical Procedures - mortality | Emergency Treatment - statistics & numerical data | Emergency Treatment - mortality | Adult | Female | Aged | Digestive System Surgical Procedures - mortality | Cohort Studies | Laparotomy - statistics & numerical data | Original
SURGERY | IMPLEMENTATION | BARRIERS | HEALTH | Elective Surgical Procedures - statistics & numerical data | Prospective Studies | World Health Organization | Humans | Middle Aged | Patient Safety - statistics & numerical data | Checklist - statistics & numerical data | Male | Survival Rate | Laparotomy - mortality | Digestive System Surgical Procedures - statistics & numerical data | Elective Surgical Procedures - mortality | Emergency Treatment - statistics & numerical data | Emergency Treatment - mortality | Adult | Female | Aged | Digestive System Surgical Procedures - mortality | Cohort Studies | Laparotomy - statistics & numerical data | Original
Journal Article